Lisata Therapeutics Statistics
NASDAQ: LSTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.17-0.04 (-3.31%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Lisata Therapeutics by the numbers
Lisata Therapeutics has a market capitalization of $12.6 million based on 10.80M shares outstanding. With trailing EPS of $-1.64, Lisata Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.1% below its 50-day average and 62.0% below its 200-day average.
Average daily trading volume is 291.98K shares, or about $341,612 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LSTA valuation vs. peer median
| Metric | LSTA | Peer median | Difference |
|---|---|---|---|
| Market cap | $12.64M | $12.65M | -0% |
| Avg. volume | 291.98K | 563.23K | -48% |
Peer median across 8 companies: BIVI, BFRG, ASBP, TPST, GDTC, LTRN, PHIO, CTXR.
Valuation
- Market cap
- $12.64M
- EPS (TTM)
- $-1.64
- Shares outstanding
- 10.80M
Price and trading
- Previous close
- 1.21
- Open
- 1.22
- Day range
- 1.16 – 1.22
- 52-week range
- 0.99 – 5.07
- 52-week change
- -52.63%
- Beta
- —
- Volume
- 13.44K
- Average volume
- 291.98K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 12.64M
- Forward Pe
- -1.01
- Eps
- -1.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.07
- Week52 Low
- 0.99
- Avg Volume
- 291.98K
- Shares Outstanding
- 10.80M
- Ma50
- 1.41
- Ma200
- 3.08
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -76.92%
- Pct From52w Low
- 18.18%